Gary Kobinger PhD, Pr. Dr., Director of the Research Centre on Infectious Diseases, Faculty of Medicine at Université Laval, Adjunct Professor, Department of Pathology and Laboratory Medicine, University of Pennsylvannia, Adjunct Professor, Department of Medical Microbiology, Faculty of Medicine, University of Manitoba, Canada.
Gary Kobinger is a professor in the Department of Microbiology and Infectious Diseases and the Director of the Research Centre on Infectious Diseases, Faculty of Medicine at Université Laval. He is also an adjunct professor in the Department of Pathology and Laboratory Medicine at the University of Pennsylvania, and an associate professor in the Department of Medical Microbiology at the University of Manitoba. His work focuses on developing and testing new vaccine platforms and immune treatments against emerging and re-emerging viruses of high consequences to public health.
Gary was granted several awards including the Faculty Teaching Award from the University of Manitoba, the 2014 the Gully award, the 2015 scientists of the year award from Radio Canada (CBC) and the Order of Manitoba in 2016.
Between 2013-2016, 60 minutes, National Geographic, BBC Horizon, NOVA, France 2, PBS and others featured the leading work on successful treatment of Ebola infection that was developed by Gary and his team. In July 2016, Gary Kobinger initiated a new chapter of his career as the Director of the Centre de Recherche en Infectiologie de l’Université Laval, Quebec, Canada.